Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

Approved by the FDA 12 years ago, pre-exposure prophylaxis (PrEP) has significantly reduced the risk of HIV transmission and ...

The Royal Pharmaceutical Society (RPS) has warned about “patient safety” after discovering that draft HIV guidance directs ...

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

With new CDC data expressing optimism about the epidemic of sexually transmitted infections (STIs), take a look at the ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the ...

A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...

In the context of World AIDS Day (December 1), the Pan American Health Organization (PAHO) has launched the “Better with PrEP ...

Indiana laws criminalizing human immunodeficiency virus (HIV) transmission are “outdated” and largely unnecessary, asserts a ...

Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves from catching HIV, but according to a new paper in the New England Journal ...

But Woodward said the increase could be slowed down if there was greater uptake in drugs that prevent HIV transmission, ...

Kenya’s ministry of health has approved the nationwide roll out of a vaginal ring to help women protect themselves from HIV.